Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jingfang Fuzi Lizhong Decoction is a Traditional Chinese Medicine (TCM) formula developed by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. It is specifically designed for the treatment of chronic ulcerative colitis characterized by the TCM syndrome of 'yang deficiency and dampness stagnation.' The decoction utilizes a therapeutic strategy known as 'warming yang and dispelling wind,' which typically involves a combination of warming agents (such as those found in the classical Fuzi Lizhong formula) and wind-dispelling herbs (Jingfang). Clinical research, including a registered interventional study in China (ChiCTR2000039127), evaluates its clinical efficacy and its impact on inflammatory signaling pathways compared to healthy and untreated control groups.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jingfang Fuzi Lizhong Decoction.